GPER1 and esophageal cancer: Estrogen, acting through estrogen receptors (nuclear receptors ERα and ERβ and membrane receptors GPER), was extensively deregulated during the development and progression of esophageal cancer [32], gastric cancer [33], and colon cancer [34].